Cizzle Biotechnology Holdings Plc
CIZ.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £182 | £365 | £484 | £144 |
| Short-Term Investments | £0 | £22 | £332 | £1,413 |
| Receivables | £72 | £103 | £107 | £136 |
| Inventory | £1 | £2 | £0 | £0 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £255 | £492 | £923 | £1,693 |
| Property Plant & Equip (Net) | £2 | £0 | £0 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £2 | £0 | £0 | £0 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £257 | £492 | £923 | £1,693 |
| Liabilities | – | – | – | – |
| Payables | £383 | £13 | £129 | £92 |
| Short-Term Debt | £150 | £0 | £0 | £0 |
| Tax Payable | £0 | £7 | £0 | £7 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £0 | £390 | £0 | £87 |
| Total Curr. Liab. | £533 | £410 | £129 | £186 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £533 | £410 | £129 | £186 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £3,507 | £40 | £3,507 | £3,504 |
| Retained Earnings | -£10,404 | -£10,036 | -£9,281 | -£47,891 |
| AOCI | -£29,290 | -£29,300 | £10,679 | £10,559 |
| Other Equity | £35,911 | £35,911 | -£4,111 | £35,335 |
| Total Equity | -£276 | £82 | £794 | £1,507 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £257 | £492 | £923 | £1,693 |
| Net Debt | -£32 | -£365 | -£484 | -£144 |